Bepridil

This classification denotes a calcium channel blocker with the molecular formula C24H34N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 755BO701MA, chemically known as 1-pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-n-phenyl-n-(phenylmethyl)- but generally known as bepridil, which bears US NIH Compound Identifier 2351. Bepridil most often comes in base and hydrochloride forms. European Medicines Agency schedules Bepridil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13041MIG. The term BEPRIDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules bepridil in its Anatomical Therapeutic Chemical (ATC) Classification. BEPRIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bepridil under HS 29339990 and SITC 51577. As of Q4 2014, BEPRIDIL remains the US FDA Preferred Term for this commodity. Bepridil bears US NLM identifiers UMLS ID C0005116 and NCI Concept Code C87448. SMILES: O(CC(N1CCCC1)CN(CC1CCCCC1)C1CCCCC1)CC(C)C.